Open Access

Roles and regulatory mechanisms of KIN17 in cancers (Review)

  • Authors:
    • Xueran Huang
    • Zichang Dai
    • Qiuyan Li
    • Xiaocong Lin
    • Qiyuan Huang
    • Tao Zeng
  • View Affiliations

  • Published online on: February 17, 2023     https://doi.org/10.3892/ol.2023.13723
  • Article Number: 137
  • Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

KIN17, which is known as a DNA and RNA binding protein, is highly expressed in numerous types of human cancers and was discovered to participate in several vital cell behaviors, including DNA replication, damage repair, regulation of cell cycle and RNA processing. Furthermore, KIN17 is associated with cancer cell proliferation, migration, invasion and cell cycle regulation by regulating pathways including the p38 MAPK, NF‑κB‑Snail and TGF‑β/Smad2 signaling pathways. In addition, knockdown of KIN17 was found to enhance the sensitivity of tumor cells to chemotherapeutic agents. Immunohistochemical analysis revealed that there were significant differences in the expression of KIN17 between cancer tissues and adjacent tissues. Both the Kaplan‑Meier survival analysis and multivariate Cox regression analysis indicated that KIN17 is aberrantly high expressed in various tumor tissues and is also associated with poor prognosis in patients with various tumor types. Taken together, KIN17 has key roles in tumorigenesis and cancer development. Investigating the relationship between KIN17 and neoplasms will provide a vital theoretical basis for KIN17 to serve as a diagnostic and prognostic biomarker for cancer patients and as a potential target for cancer therapy.
View Figures
View References

Related Articles

Journal Cover

April-2023
Volume 25 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huang X, Dai Z, Li Q, Lin X, Huang Q and Zeng T: Roles and regulatory mechanisms of KIN17 in cancers (Review). Oncol Lett 25: 137, 2023
APA
Huang, X., Dai, Z., Li, Q., Lin, X., Huang, Q., & Zeng, T. (2023). Roles and regulatory mechanisms of KIN17 in cancers (Review). Oncology Letters, 25, 137. https://doi.org/10.3892/ol.2023.13723
MLA
Huang, X., Dai, Z., Li, Q., Lin, X., Huang, Q., Zeng, T."Roles and regulatory mechanisms of KIN17 in cancers (Review)". Oncology Letters 25.4 (2023): 137.
Chicago
Huang, X., Dai, Z., Li, Q., Lin, X., Huang, Q., Zeng, T."Roles and regulatory mechanisms of KIN17 in cancers (Review)". Oncology Letters 25, no. 4 (2023): 137. https://doi.org/10.3892/ol.2023.13723